Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceGlobeNewsWire • 10/31/23
The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorganMarket Watch • 10/24/23
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process IntensificationGlobeNewsWire • 08/17/23
Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceGlobeNewsWire • 08/02/23
Earnings Preview: Repligen (RGEN) Q2 Earnings Expected to DeclineZacks Investment Research • 07/26/23
Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceGlobeNewsWire • 05/02/23
Repligen (RGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/25/23